| 000 | 01709 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514221753.0 | ||
| 264 | 0 | _c20050407 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a0012-3692 | ||
| 024 | 7 |
_a10.1378/chest.127.3.909 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDresler, Carolyn M | |
| 245 | 0 | 0 |
_aPhase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. _h[electronic resource] |
| 260 |
_bChest _cMar 2005 |
||
| 300 |
_a909-15 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsufflation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPleural Effusion, Malignant _xtherapy |
| 650 | 0 | 4 |
_aPleurodesis _xadverse effects |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aTalc _xadministration & dosage |
| 650 | 0 | 4 | _aThoracoscopy |
| 650 | 0 | 4 | _aThoracostomy |
| 700 | 1 | _aOlak, Jemi | |
| 700 | 1 | _aHerndon, James E | |
| 700 | 1 | _aRichards, William G | |
| 700 | 1 | _aScalzetti, Ernest | |
| 700 | 1 | _aFleishman, Stewart B | |
| 700 | 1 | _aKernstine, Kemp H | |
| 700 | 1 | _aDemmy, Todd | |
| 700 | 1 | _aJablons, David M | |
| 700 | 1 | _aKohman, Leslie | |
| 700 | 1 | _aDaniel, Thomas M | |
| 700 | 1 | _aHaasler, George B | |
| 700 | 1 | _aSugarbaker, David J | |
| 773 | 0 |
_tChest _gvol. 127 _gno. 3 _gp. 909-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1378/chest.127.3.909 _zAvailable from publisher's website |
| 999 |
_c15437638 _d15437638 |
||